INNATE PHARMA SA-SPONS ADR (IPHA)

US45781K2042 - ADR

2.5454  +0.12 (+4.75%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
51.90M49.58M12.11M56.16M68.97M
Cost Of Goods
2.85M3.58M3.06M3.59M3.21M
Gross Profit
49.05M46.00M9.05M52.56M65.77M
Operating Expenses
61.72M62.42M56.87M51.49M92.82M
Research and Development
49.44M45.46M41.21M37.74M59.97M
Selling, General, and Administrative Expenses
16.69M20.24M23.35M17.54M23.95M
Operating Income
-12.67M-16.42M-47.83M1.08M-27.05M
Interest Income/Expense
3.45M1.09M1.26M-1.36M2.21M
Other Income/Expense
1.65M-1.63M1.08M-552.00K4.08M
Non Recurring Items
0.00-41.00MN/A-43.53MN/A
Income Before Taxes
-7.57M-57.97M-45.48M-829.00K-20.76M
Income Tax
0.000.000.000.000.00
Net Income
-7.57M-58.10M-52.81M-63.98M-20.76M
EBITDA
-7.58M28.98M-43.23M57.88M-10.52M
 
Per Share Data
EPS Diluted Total Ops
-0.09-0.73-0.66-0.81-0.31
 
Statistics
Gross Profit Margin
94.50%92.78%74.69%93.61%95.35%
Profit Margin
-14.59%-117.19%-436.01%-113.94%-30.10%
Operating Profit Margin
-24.41%-33.13%-394.86%1.92%-39.22%

All data in EUR

Charts